Access to better care, rapid intervention, and standardized procedures with predictable outcomes is critical for treating ...

Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...

Imperative Care, Inc. announced the FDA 510(k) clearance of and first patient cases with its Zoom 7X catheter for aspiration ...

Perfuze, an Ireland-based developer of catheters for interventional stroke care, recently announced preliminary results from ...

Arsenal Medical recently announced findings from the EMBO-02 clinical study evaluating NeoCast, the company’s next-generatio ...

However, this is the past; this article details the present and the near future. Several platforms have been evaluated in ...

InterVene, Inc., a developer of interventional devices for venous inflow and outflow obstructions, announced that the ...

The evolution of reimbursement models, the challenge of budget neutrality mandates and decreasing reimbursements in the ...

Imperative Care, Inc. announced findings from a subanalysis of patients with M2 occlusions enrolled in the Imperative Trial ...

A discussion on pathophysiology, patient workup, gaps in data and disease-specific tools, and postprocedural follow-up and ...

AngioDynamics, Inc. announced the publication of results from the PRESERVE study, which assessed the safety and effectiveness of i ...

Getinge announced that its iCast covered stent system has received FDA premarket approval for a new indication. The iCast ...